Trial to Evaluate Immune Response After Vaccination in Pediatric Patients With Cancer
Patients in the first arm will undergo single booster vaccination, and patients in the second arm will undergo full revaccination.
Diagnosis & Disease Information
Pfizer-BioNTech COVID-19 Booster Authorized for 16- and 17-Year-Olds
Individuals in this age group should only receive this vaccine as their booster.
mRNA Vaccine Effective Against Hospitalization Over 24-Week Period
Pfizer-BioNTech and Moderna vaccines effective against COVID-19-associated hospitalizations among adults
FDA Grants First Full Approval to Pfizer-BioNTech COVID-19 Vaccine
The approval is indicated for individuals 16 years of age and older, however the vaccine remains available to those aged 12 years and older under the EUA.
Can Patients With Multiple Myeloma Boost Their Immunity?
Multiple myeloma (MM) is not a disease with a known cure, but recent studies have suggested that focusing on boosting immunity in patients with MM may help their chances at longer-term survival. What are these immunity-focused treatment options?
COVID-19 Vaccination and Imaging Misinterpretation: An Interview With Lacey McIntosh, DO, MPH
Oncologists and patients should be aware of the potential manifestations of the COVID-19 vaccination on imaging and the consequences this might have on disease assessment, treatment monitoring, and decision-making.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...